PubMed

Prevalence and treatment of low HDL cholesterol among primary care patients with type 2 diabetes: an unmet challenge for cardiovascular risk reduction.

Grant RW, Meigs JB.

Diabetes Care. 2007 Mar;30(3):479-84.PMID: 17327308 [PubMed - indexed for MEDLINE]Related articlesFree article

Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.

Nesto RW.

Am J Cardiovasc Drugs. 2005;5(6):379-87. Review.PMID: 16259526 [PubMed - indexed for MEDLINE]Related articles

The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.

Nichols GA, Koro CE, Chan W, Bowlin SJ, Sprecher DL.

Clin Ther. 2006 Feb;28(2):243-50.PMID: 16678645 [PubMed - indexed for MEDLINE]Related articles

Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial.

Holman RR, Paul S, Farmer A, Tucker L, Stratton IM, Neil HA; Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes Study Group.

Diabetologia. 2009 Jan;52(1):50-9. Epub 2008 Nov 11.PMID: 19002433 [PubMed - indexed for MEDLINE]Related articles

Prevalence and treatment of dyslipidemia in Canadian primary care: a retrospective cohort analysis.

Petrella RJ, Merikle E, Jones J.

Clin Ther. 2007 Apr;29(4):742-50.PMID: 17617298 [PubMed - indexed for MEDLINE]Related articles

Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.

Hausenloy DJ, Yellon DM.

Heart. 2008 Jun;94(6):706-14. Review.PMID: 18480348 [PubMed - indexed for MEDLINE]Related articles

Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.

Ferdinand KC.

J Cardiometab Syndr. 2006 Spring;1(2):133-40. Review.PMID: 17679832 [PubMed - indexed for MEDLINE]Related articles

Low HDL-cholesterol is common in European Type 2 diabetic patients receiving treatment for dyslipidaemia: data from a pan-European survey.

Bruckert E, Baccara-Dinet M, Eschwege E.

Diabet Med. 2007 Apr;24(4):388-91. Epub 2007 Feb 28.PMID: 17335463 [PubMed - indexed for MEDLINE]Related articles

Benefits of lipid-lowering therapy in patients with type 2 diabetes mellitus.

Betteridge J.

Am J Med. 2005 Dec;118 Suppl 12A:10-5.PMID: 16356802 [PubMed - indexed for MEDLINE]Related articles

Non-HDL cholesterol and apolipoprotein B predict cardiovascular disease events among men with type 2 diabetes.

Jiang R, Schulze MB, Li T, Rifai N, Stampfer MJ, Rimm EB, Hu FB.

Diabetes Care. 2004 Aug;27(8):1991-7.PMID: 15277429 [PubMed - indexed for MEDLINE]Related articlesFree article

Reducing cardiovascular risk in diabetes: beyond glycemic and blood pressure control.

Hobbs FD.

Int J Cardiol. 2006 Jun 16;110(2):137-45. Epub 2005 Nov 11. Review.PMID: 16289373 [PubMed - indexed for MEDLINE]Related articles

Cholesterol levels and statin use in patients with coronary heart disease treated in primary care settings.

O'Connor PJ, Gray RJ, Maciosek MV, Fillbrandt KM, DeFor TA, Alexander CM, Weiss TW, Teutsch SM.

Prev Chronic Dis. 2005 Jul;2(3):A05. Epub 2005 Jun 15.PMID: 15963307 [PubMed - indexed for MEDLINE]Related articlesFree article

Combining population health and baseline risk strategy by determining an age cutoff for initiating statins in patients with diabetes: a population-based study.

Siyambalapitiya S, Bulugahapitiya U, Sithole J, Song S, Fernando DJ, Idris I.

Diabetes Care. 2007 Aug;30(8):2025-9. Epub 2007 May 22.PMID: 17519429 [PubMed - indexed for MEDLINE]Related articlesFree article

Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.

Van Ganse E, Laforest L, Burke T, Phatak H, Souchet T.

Clin Ther. 2007 Aug;29(8):1671-81.PMID: 17919548 [PubMed - indexed for MEDLINE]Related articles

Impact of using a non-diabetes-specific risk calculator on eligibility for statin therapy in type 2 diabetes.

Price HC, Coleman RL, Stevens RJ, Holman RR.

Diabetologia. 2009 Mar;52(3):394-7. Epub 2008 Dec 2.PMID: 19048226 [PubMed - indexed for MEDLINE]Related articles

Cholesterol and atherosclerosis: a contemporary perspective.

Kashyap ML.

Ann Acad Med Singapore. 1997 Jul;26(4):517-23. Review.PMID: 9395824 [PubMed - indexed for MEDLINE]Related articles

[HDL cholesterol and cardiovascular disease in a population with hypertension and type 2 diabetes mellitus. RICARHD Study]

Conthe P, Gómez-Fernández P, de Alvaro F, Fernández-Pérez C, González-Esteban J, Cea-Calvo L; Investigadores del estudio RICARHD.

Rev Clin Esp. 2009 May;209(5):227-33. Spanish. PMID: 19480779 [PubMed - indexed for MEDLINE]Related articles

Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.

Alsheikh-Ali AA, Lin JL, Abourjaily P, Ahearn D, Kuvin JT, Karas RH.

Am J Cardiol. 2007 Nov 15;100(10):1499-501. Epub 2007 Sep 27.PMID: 17996508 [PubMed - indexed for MEDLINE]Related articles

Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

Evans M, Roberts A, Davies S, Rees A.

Drugs. 2004;64(11):1181-96. Review.PMID: 15161326 [PubMed - indexed for MEDLINE]Related articles

High prevalence of low HDL-cholesterol in a pan-European survey of 8545 dyslipidaemic patients.

Bruckert E, Baccara-Dinet M, McCoy F, Chapman J.

Curr Med Res Opin. 2005 Dec;21(12):1927-34.PMID: 16368042 [PubMed - indexed for MEDLINE]Related articles